Janke P G, Diggins J B, Currie W J, Dasgupta P K, Glick E N, Sheikh N A
Pharmatherapeutica. 1984;3(10):663-7.
Ninety-five geriatric patients with osteoarthritis of the hip and/or knee were entered into an open parallel group study of sulindac (400 mg/day) and naproxen (500 mg/day), both given in twice-daily regimens. Patients received the drugs for 12 weeks. Both drugs produced improvements in the patients' overall condition. There were no statistically significant differences between the effects of the two drugs. Overall, both drugs proved beneficial and well tolerated.
95名患有髋部和/或膝部骨关节炎的老年患者参与了一项关于舒林酸（400毫克/天）和萘普生（500毫克/天）的开放性平行组研究，两种药物均采用每日两次的给药方案。患者接受药物治疗12周。两种药物均使患者的整体状况得到改善。两种药物的疗效之间没有统计学上的显著差异。总体而言，两种药物都证明是有益的且耐受性良好。
